Patent intelligence · US
US 7317127
Process for the optical resolution and recycling of tomoxetine
Process for the optical resolution and recycling of tomoxetine
Patent details — US 7317127
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 8, 2008
- Expiration
- Jan 3, 2028
- Claims
- 26
- CPC classes
- A61P, A61P25/00, A61P43/00
Quick answer
US 7317127 (Process for the optical resolution and recycling of tomoxetine) is held by Teva Pharmaceutical Fine Chemicals S.R.L.. Status: granted. Granted Jan 8, 2008. Expires Jan 3, 2028 (1 year remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- 26
- CPC classes
- A61P, A61P25/00, A61P43/00
More from Teva Pharmaceutical Fine Chemicals S.R.L.
Related pharmaceutical patents in our USPTO index.
-
US 12310929
Use of rasagiline for the treatment of restless legs syndrome
granted -
US 12258401
Anti-CD47 combination therapy
granted -
US 12157729
Solid state forms of Belumosudil and Belumosudil salts
granted -
US 12139528
Treating refractory migraine
granted -
US 12091388
Solid state forms of Reproxalap
granted -
US 11826322
Pre-filled syringe
granted -
US 11813359
Sustained release olanzapine formulations
granted -
US 11773083
Solid state forms of Belumosudil and Belumosudil salts
granted
Related coverage
BBSW AI Solution: Key Insights from the 2026 Event
The BBSW AI Solution event in Foster, USA, promises to unveil critical advancements in AI technology for the pharma industry. Stay tuned for live updates and key takeaways.
BBSW AI Solution 2026: Key Insights and Highlights
The BBSW AI Solution event in 2026 is set to unveil groundbreaking advancements in AI technology. Join us for live coverage and key insights from industry leaders.
Frequently asked questions
What is US patent 7317127?
US 7317127 (Process for the optical resolution and recycling of tomoxetine) is held by Teva Pharmaceutical Fine Chemicals S.R.L.. Status: granted. Granted Jan 8, 2008. Expires Jan 3, 2028 (1 year remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7317127?
Teva Pharmaceutical Fine Chemicals S.R.L. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 454 pharmaceutical patents for this assignee.
When does US 7317127 expire?
Our index shows an expiration date of Jan 3, 2028 (1 year from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.